Serhan Can İsCan

Serhan Can İsCan

Auto-generated profile, based on publicly available information

Serhan Can İsCan

Kütahya Health Sciences University, Department of Obstetrics and Gynecology, Kütahya, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
SESehnaz Evrimler
Sehnaz Evrimler
SISerhan Can Iscan
Serhan Can Iscan
GIGokce Iscan
Gokce Iscan
JRJalal Raoufi
Jalal Raoufi
EEEvrim Erdemoglu
Evrim Erdemoglu

24 January 2022 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
GIGokce Iscan
Gokce Iscan
BCBulent Cetin
Bulent Cetin
FKFaruk Kilic
Faruk Kilic
HKHakan Kalayci
Hakan Kalayci
AKAysegul Kalayci
Aysegul Kalayci
SISerhan Can Iscan
Serhan Can Iscan

28 December 2020 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
FAFatih Akkuş
Fatih Akkuş
SISerhan Can İşCan
Serhan Can İşCan
JRJalal Raoufi
Jalal Raoufi
MGMehmet Güney
Mehmet Güney
EEEvrim Erdemogľu
Evrim Erdemogľu
To investigate the effect of using magnifying loupes during surgery on surgical outcomes and lymphocele formation. We prospectively enrolled 36 patients with gynecologic cancer who underwent pelvic and para-aortic lymphadenectomy. Age, body mass index, menopausal status, type of cancer, comorbid diseases, preoperative albumin and albumin replacement therapy, performance status, serum CA125, hemoglobin, platelets and white blood cells, surgical procedure, blood loss, blood transfusion, the count of removed lymph nodes, presence of metastatic lymph nodes, total amount of drainage, postoperative complications, operation length, and count of used hemoclips were recorded. Patients were randomized into two groups: group 1 operated using loupe glasses, and group 2, without loupes. In the loupe-negative group, total drainage volume was 6698 mL, whereas in the loupe-positive group, it was only 1049 mL (p<0.01). Postoperatively, the mean drainage duration was 10.6±5.1 days in loupe-negative group and 4.8±2.4 days in the loupe-positive group (p=0.0001). There were no differences between the two groups in terms of surgical site infections, fascial defects, and pulmonary thromboembolism (p=0.39, 0.33, 0.59, respectively). There was no significant difference in the number of harvested lymph nodes in patients who underwent surgery with or without loupes being used. The count of used hemoclips were 50.22±8.05 and 41.38±9.7 for the loupe-negative and positive groups, respectively (p<0.01). There was no lymphocele in the loupe-positive group, but we detected 5 (27.8%) lymphocele in the loupe-negative group (p=0.05). Gynecologic oncologic surgeons can add magnifying loupe glasses to their armament and benefit from this technical device; lymphocele development, total drainage volume, length of drainage time, and clip counts can be decreased by using loupe glasses in gynecologic cancer surgery.

21 June 2018 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
JRJalal Raoufi
Jalal Raoufi
SISerhan Can İşcan
Serhan Can İşcan
CHCandost Hanedan
Candost Hanedan
EOEmine Elif Ozkan
Emine Elif Ozkan
SÇSevim Süreyya Çerçi
Sevim Süreyya Çerçi
EEEvrim Erdemogľu
Evrim Erdemogľu
There is scarce information about axillary lymph node involvement in gynecologic cancers. We analyzed the incidence of suspicious axillary lymph nodes in gynecologic cancers. We retrospectively analyzed the positron emission tomography/computed tomography findings of 251 patients with endometrial, cervical, and ovarian cancer. There is no cut-off value documented for axillary metastases from gynecologic cancers; therefore we adopted the cut-off standardized uptake values (SUVs) proclaimed in breast cancer. A total of 251 patients records were available for analysis; 40 patients (15.9%) with suspicious axillary lymph nodes were included in the study. Twenty-one and a half percent (n=20/93) of patients with endometrium cancer, 14.1% (n=14/99) of patients with ovarian cancer, and 10% (n=6/59) of those with cervical cancer had suspicious axillary lymph nodes. Patients with an maximum SUV (SUVmax) uptake higher than 3 underwent axillary lymph node biopsy. None of them was found to have axillary metastases of gynecologic cancers in the pathologic evaluation. In one patient with endometrial cancer, an obscure breast ductal carcinoma was diagnosed, another patient with endometrial cancer was found to have follicular lymphoma. The third patient with endometrial cancer had no malignancy in axillary lymph node biopsy, but had Hurthle cell neoplasia in a thyroid biopsy; the patient did not accept any surgical or medical treatment for endometrial cancer and died 23 months later. There were three (7.5%) metachronous cancers out of 40 gynecologic cancers; two patients were explained above, the third patient with endometrium cancer, who was not histopathologically evaluated although the axillary SUVmax was <3, had rectosigmoid cancer and glioblastoma metachronously. Our study shows that an important ratio (14-21%) of patients with gynecologic cancer has suspicious axillary lymph nodes. Increased SUVmax, particularly above 3, might be used as an indication for axillary biopsy and may help to identify secondary metastatic cancer.

10 October 2019 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Closed access
ÇBÇağlayan Biçer
Çağlayan Biçer
JRJalal Raoufi
Jalal Raoufi
SISerhan Can İşCan
Serhan Can İşCan
MGMehmet Güney
Mehmet Güney
EEEvrim Erdemogľu
Evrim Erdemogľu
Preoperative surgical risk assessment is important in terms of postoperative morbidity and mortality. Therefore, it is necessary to evaluate the efficacy and safety of these surgeries via an ideal risk assessment model, and reduce risks via applying some findings (for instance, perioperative beta-blockers). There are some risk assessment systems, but these have generally not been verified for patients with gynecologic cancer. The aim of this study was to assess the risk of surgery for gynecological oncologic patients and suggest an easy risk assessment model and risk reduction by applying our findings. We retrospectively analyzed 258 gynecologic patients with cancer. Age, diagnosis, staging, performance scale, metoprolol use, heart, renal diabetes, Chronic Obstructive Pulmonary disease, diabetes, operation type and length, carcinoma antigen 125, ascites, albumin, surgical procedure, hospitalization length, and complications were recorded. Of the 258 patients, 173 patients (67.1%) had no complications, 43 patients (16.7%) had one and 42 patients (16.3%) had two or more complications. The most common complication was the acid-base imbalance (14%), followed by urinary tract infection (9.7%). Parameters associated with complications were performance status, ascites, operating length, metoprolol use, and upper abdominal surgery. In our proposed scoring model with a total score range 0-23, cut-off value points for both the presence and rate of complications was found as >5. In gynecological patients with cancer, the addition of metoprolol use and upper abdominal surgery within preoperative risk assessment evaluation parameters are significantly effective in predicting the rate and severity of complications. Moreover, we have suggested a simple, practical, and convenient scoring model for this evaluation.

7 April 2026 in Fertility and Sterility
Verified
Journal Article
Closed access
IBIsmail Biyik
Ismail Biyik
HSHatice Sari
Hatice Sari
SISerhan Can Iscan
Serhan Can Iscan